Asitri Dashboard
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 28
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT03633227 | Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment | ||
NCT00570765 | Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC) | ||
NCT05292872 | Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients | ||
NCT01914562 | Effect of Food on Pharmacokinetics of Obeticholic Acid (OCA) | ||
NCT04594694 | Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBC | ||
NCT00550862 | Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC) | ||
NCT00501592 | Study of INT-747 in Patients With Diabetes and Presumed NAFLD | ||
NCT02846896 | The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland | ||
NCT04265235 | EXerCise Intervention in cholesTatic LivEr Disease: The EXCITED Study | ||
NCT01904539 | Hepatic Impairment Trial of Obeticholic Acid | ||
NCT02039219 | Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH) | ||
NCT05239468 | Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC | ||
NCT02177136 | Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC) | ||
NCT02654236 | Effect of Heavy Alcohol Consumption on Farnesoid X Receptor (FXR) Signaling | ||
NCT01865812 | Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis | ||
NCT06121375 | Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomy | ||
NCT01933503 | Single Dose and Multiple Dose Trial to Assess Pharmacokinetics of Obeticholic Acid (OCA) | ||
NCT05639543 | FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) Study | ||
NCT05479721 | LITMUS Imaging Study | ||
NCT05293938 | A Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients | ||
NCT05321524 | Obeticholic Acid in Pediatric Subjects With Biliary Atresia | ||
NCT01473524 | Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis | ||
NCT05740631 | The Effect of Obeticholic Acid in Healthy Volunteers | ||
NCT02633956 | Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL) | ||
NCT02548351 | Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment | ||
NCT02308111 | Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis | ||
NCT06488911 | To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate | ||
NCT03439254 | Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis |